Innovus Pharmaceuticals, Inc. has acquired Semprae Laboratories, Inc. Based in NJ, Semprae focuses on developing products for women’s sexual health and currently markets two OTC products, Zestra and Zestra Glide, which had sales of approximately $1 million in 2013.
 
Innovus Pharma currently has two products targeting male sexual health including EjectDelay for premature ejaculation and CIRCUMserum to help alleviate reduced sensitivity.
 
“This acquisition of Semprae moves Innovus Pharma into the commercial revenue-generating stage with needed products in the female sexual health space,” said Dr. Bassam Damaj, president and chief executive officer of Innovus Pharma. “In addition, it gives Innovus the needed retail infrastructure for distributing the rest of our OTC products in the U.S. The combination of Semprae’s two products with those of Innovus Pharma creates a company that is clearly an emerging leader in the over the counter male and female sexual health space.”